The higher interleukin-15 and interleukin-6 concentrations in the group of newly diagnosed diabetes in our study could be associated with poor metabolic compensation at the moment of diagnosis, but similar results were also found in the group of first-degree relatives who did not have metabolic disturbances. Here, IL6 is linked to diabetes mellitus.